Rating Change
Evercore ISI Group analysts downgraded Legend Biotech Corporation (NASDAQ:LEGN) from Outperform to In-Line on November 16, 2026.
Evercore ISI Group analysts downgraded Legend Biotech Corporation (NASDAQ:LEGN) from Outperform to In-Line on November 16, 2026.

At publication ·
Legend Biotech Corporation (NASDAQ:LEGN) · downgrade
At a glance
Evercore ISI Group analysts downgraded Legend Biotech Corporation (NASDAQ:LEGN) from Outperform to In-Line on November 16, 2026.
Legend Biotech Corporation operates in the Healthcare sector. The stock currently trades at $15.99 with a market capitalization of $2.1B. The stock has declined 43.9% over the past 52 weeks.
Analyst downgrades can weigh on a stock in the short term as institutional investors who follow Evercore ISI Group's research adjust their positions. However, downgrades also sometimes create buying opportunities if the market overreacts to the rating change. The reasoning behind the downgrade matters more than the rating itself.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 7 Buy, 3 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Nov 16, 2026 | Evercore ISI Group | In-Line | N/A |
| Nov 11, 2026 | RBC Capital | Outperform | N/A |
| Nov 11, 2026 | Barclays | Overweight | N/A |
| Nov 11, 2026 | Morgan Stanley | Overweight | N/A |
| Nov 11, 2026 | Oppenheimer | Perform | N/A |
Related Tools: Analyst Ratings Dashboard | View LEGN Stock Page
A rating of In-Line from Evercore ISI Group reflects the analyst's outlook on Legend Biotech Corporation (NASDAQ:LEGN). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the LEGN forecast page.
Keep reading
analyst ·
analyst ·
analyst ·
analyst ·
Current market data
NASDAQ · LEGN
$17.50
Down: -$1.51 · -8.63%
Live quote updated